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abstract: Odontogenic tumours are lesions that occur solely within the oral cavity and are so named because 
of their origin from the odontogenic (i.e. tooth-forming) apparatus. Odontogenic tumours comprise a variety 
of lesions ranging from non-neoplastic tissue proliferations to benign or malignant neoplasms. However, 
controversies exist regarding the pathogenesis, categorisation and clinical and histological variations of these 
tumours. The recent 2017 World Health Organization classification of odontogenic tumours included new entities 
such as primordial odontogenic tumours, sclerosing odontogenic carcinomas and odontogenic carcinosarcomas, 
while eliminating several previously included entities like keratocystic odontogenic tumours and calcifying cystic 
odonogenic tumours. The aim of the present review article was to discuss controversies and recent concepts 
regarding odontogenic tumours so as to increase understanding of these lesions. 
Keywords: Neoplasms; Oral Cavity; Odontogenic Tumors; Hamartomas; Classification; World Health Organization.
امللخ�ص: االأورام �سنية املن�ساأ هي اآفات حتدث بالتحديد يف جوف الفم وح�سب الت�سمية تن�ساأ من اخلاليا املن�ساأة لالأ�سنان. ت�سم االأورام 
�سنية املن�ساأ على العديد من االآفات ترتاوح من تكاثر االأن�سجة غري ال�رصطانية اإىل االأورام احلميدة واخلبيثة. على الرغم من هذا، توجد 
اإختالفات يف االإمرا�ص والت�سنيف والتنوع االأكلينيكي واملجهري لهذه االأورام. �سمل الت�سنيف اجلديد 2017 لالأورام �سنية املن�ساأ ملنظمة 
ال�سحة العاملية على كيانات جديدة مثل اأورام اأولية �سنية املن�ساأ، �رصطانات م�سلبة �سنية املن�ساأ، و�ساركومة �رصطانية �سنية املن�ساأ، مع 
اإ�ستبعاد العديد من الكيانات املدرجة �سابقا كاأورام الكي�سة الكرياتينية �سنية املن�ساأ واالأورام الكي�سية املكل�سة �سنية املن�ساأ. تهدف هذه 
املراجعة اإىل مناق�سة هذه االإختالفات واملفاهيم احلديثة املتعلقة باالأورام �سنية املن�ساأ لزيادة فهم هذه االأورام.
الكلمات املفتاحية: اأورام؛ جوف الفم؛ اأورام �سنية املن�ساأ؛ اأورام عابية؛ ت�سنيف؛ منظمة ال�سحة العاملية.
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Many lesions, both intraosseous and extraosseous, can involve the maxillary and mandibular regions of the jaw; of 
these, odontogenic tumours are unique to the oral 
cavity and do not occur elsewhere in the body. 
These tumours originate from tissues involved in 
odontogenesis (i.e. tooth development) and include a 
wide variety of lesions ranging from hamartomas to 
non-neoplastic tissue proliferations and both benign 
and malignant neoplasms.1,2 Due to this wide range 
of biological behaviour, there is currently much 
debate regarding the pathogenesis, classification and 
clinical and histological variations of odontogenic 
tumours.1 The present review aimed to provide 
insight into different controversies and recent 
developments in this field, particularly with regards to 
the recent 2017 World Health Organization (WHO) 
classification of odontogenic tumours.2 Awareness of 
such controversies may aid in a better understanding 
of these pathological entities as well as enhancing 
their diagnosis and management. A brief overview 
of the main controversies associated with different 
odontogenic lesions is shown in Table 1.
Classification
Odontogenic lesions were first classified by Broca in 
1868.3 In 1971, the WHO included these lesions in its 
first histological classification of such tumours and 
provided the clinicopathological criteria necessary 
for diagnosis.1 Due to subsequent advancements in 
diagnostic immunohistochemistry, molecular biology 
and genetics, as well as clinical and epidemiological 
follow-up, modifications were made to the previous 
2005 WHO classification in 2017 wherein some lesions 
were newly added, removed or reclassified; in addition, 
attempts were made to simplify the classification 
system, discarding subtypes or suffixes that lacked 
clinical relevance.2,4,5 Table 2 provides a summary 
of the entities which were either newly included or 
excluded from the WHO 2017 classification.2,4
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Nevertheless, researchers have argued that 
classifying odontogenic tumours as either benign or 
malignant does not encompass the reported range of 
behaviours shown by these lesions.6 As such, classifying 
these lesions in a manner similar to the WHO bone 
and soft tissue tumour classification—with the 
addition of intermediate (locally aggressive) and 
intermediate (rarely metastasising) categories—may 
be more appropriate.6,7 In 2016, Singh et al. proposed 
a classification for odontogenic tumours based on 
histopathological patterns; unfortunately, some of the 
classified lesions had overlapping histological features, 
thus limiting their diagnostic utility.8 The current 
review article categorises benign odontogenic lesions 
as either epithelial, mixed or mesenchymal lesions 
while malignant lesions are divided into carcinomas, 
sarcomas and carcinosarcomas.
Benign Epithelial Odontogenic 
Tumours
Due to their odontogenic potential, oral epithelial 
tissues may give rise to epithelial odontogenic 
tumours. These tumours can originate from the 
remnants of odontogenic epithelia such as reduced 
enamel epithelium and the respective epithelial cell 
rests of Malassez and Serres.9 
Table 1: Key controversies in the pathogenesis, categorisation and clinical and histological variations of 
odontogenic tumours
Entity Controversy
Benign epithelial odontogenic tumours
Peripheral ameloblastoma This lesion may be either a hamartoma or a benign neoplasm
Peripheral ameloblastomas and intraoral basal 
cell carcinomas
These may be separate entities or variants of the same entity
Calcifying epithelial odontogenic tumour The biochemical nature and origin of the amyloid-like material in this lesion is 
not yet understood
Keratocystic odontogenic tumour/ 
odontogenic keratocyst
There is debate as to whether this lesion is a cyst or tumour
Adenomatoid odontogenic tumour This lesion may be either a hamartoma, cyst or neoplasm
Squamous odontogenic tumour This lesion may be either a hamartoma or a neoplasm
Benign mixed epithelial and mesenchymal 
odontogenic tumours
Complex and compound odontomas There seems to be little clinical relevance in distinguishing these lesions as two 
separate entities
Ameloblastic fibroma Both a neoplastic and hamartomatous line of development have been proposed 
for this entity
Primordial odontogenic tumour There is doubt as to whether this is a new entity or a variant of ameloblastic 
fibromas, odontogenic fibromas or myxomas
Calcifying cystic odontogenic tumour/
calcifying odontogenic cyst 
This lesion may be either a cyst or a tumour
Benign mesenchymal odontogenic tumours
Odontogenic fibroma There is doubt regarding the subcategorisation of this entity into epithelium-rich 
and epithelium-poor variants
Odontogenic myxoma There is controversy regarding the pathogenesis of this lesion and whether it is 
truly odontogenic in nature
Cementoblastoma This lesion may have either an odontogenic or osteogenic origin
Cemento-ossifying fibroma This lesion may have either an odontogenic or fibro-osseous nature
Malignant odontogenic tumours
Clear cell odontogenic carcinomas and clear 
cell ameloblastomas
These may be separate entities or variants of the same entity
Ghost cell odontogenic carcinoma There is doubt as to whether the presence of ghost cells would cause malignancy
Sclerosing odontogenic carcinoma There is as yet no confirmation of the metastatic potential of this lesion
Odontogenic carcinosarcoma The existence of this lesion is questionable
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ameloblastoma 
In the categorisation of conventional ameloblastomas 
in the 2017 WHO classification, solid/multicystic 
adjectives were eliminated as they were deemed 
to have no biological implications and could be 
confused with unicystic ameloblastomas.4 Desmoplastic 
ameloblastomas, which had been sub-categorised 
under ameloblastomas in the previous 2005 
WHO classification, were also removed as they 
were considered a histological variant similar to 
conventional ameloblastomas.4,5 Metastasising amelo- 
blastomas were reclassified as benign tumours rather 
than malignant odontogenic tumours as these tumours 
show benign histopathology in spite of their metastatic 
potential, rendering them difficult to differentiate histo- 
pathologically from conventional ameloblastomas.2 
Based on the innocuous nature of peri-
pheral ameloblastomas (PAs), Philipsen et al. 
questioned whether such lesions were analogous 
to solid multicystic ameloblastomas (SMAs) or 
hamartomatous lesions.10 Indeed, the biological 
behaviour of a PA has been deemed more indicative 
of a hamartomatous proliferation or persistent 
hyperplasia than neoplasia.11 Marx et al. defined a 
PA as a hamartomatous proliferation of odontogenic 
epithelia arising from the rests of Serres or perhaps 
from the basal cells of the oral mucosa.12 However, the 
occurrence of intraoral basal cell carcinomas (BCCs) 
in the mucous membranes or tooth-bearing areas 
is not accepted by some investigators; thus, debate 
exists as to whether BCCs and PAs actually represent 
two distinct entities or the same lesion.13 In spite of 
many histological similarities between PAs and BCCs, 
Reichart et al. and Sciubba have claimed that PAs 
deserved to be recognised as a separate entity.9,14 In 
addition, Brierley et al. believed that while PAs may 
resemble BCCs histopathologically, a distinction 
was possible using immunohistochemical stains for 
BerEp4 and cytokeratin (CK) 19.6
calcifying epithelial 
odontogenic tumour
To date, the biochemical mechanism and the 
origin of amyloid material in calcifying epithelial 
odontogenic tumours (CEOTs) is still unknown. 
Immunohistochemical and electron microscope 
research has suggested a possible degenerative process 
involving CK intermediate filaments in tumour cells, 
while other investigators consider that the degeneration 
of type IV collagen associated with the basement 
membrane is responsible for amyloid derivation.15 
Murphy et al. determined through immunological and 
chemical analysis that amyloid associated with CEOTs 
is formed by the N-terminal fragments of a 153-residue 
protein coded by exons 5–10 of the odontogenic 
ameloblast-associated protein; this protein, along with 
green birefringent congophilic material, was detected 
in unerupted tooth follicles.16
keratocystic odontogenic 
tumour/odontogenic keratocyst 
The renaming of odontogenic keratocysts (OKCs) 
as keratocystic odontogenic tumours (KCOTs) has 
been one of the most controversial changes in the 
nomenclature of odontogenic lesions in recent years.17 
This entity shows characteristics of both a cyst and a 
benign tumour and differs from other odontogenic 
cysts due to the appearance of mural growth with 
proliferation of the lining into the cancellous bone, 
instead of centripetal growth and expansion; thus, such 
lesions may reach a considerable size before the bony 
expansion becomes clinically apparent. Furthermore, 
the high recurrence rate suggests the aggressive 
Table 2: Summary of lesions either newly excluded, 
included or recategorised in the 2017 World Health 
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This tumour has been proposed 
to be a distinct entity from other 
odontogenic carcinomas due to 
its hyalinized or sclerosing stroma
Odontogenic 
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New research has reconfirmed 
the existence of this lesion
Cemento-ossifying 
fibroma
This lesion has been included due 
to its exclusive occurrence within 





This lesion has been recategorised 
as benign due to its benign 
histopathology
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behaviour and inherent potential for growth of this 
lesion.18 However, the association of KCOTs/OKCs 
with BCCs in nevoid BCC syndrome, along with 
the fact that a subset of OKCs have similar patched 
homolog (PTCH) gene mutations to those found in 
BCC cases, is suggestive of a neoplastic nature.18 
For this reason, in 2005 the WHO categorised OKC 
as a benign odontogenic neoplasm and changed the 
nomenclature of OKC to KCOT.2 This classification 
was not fully accepted and many authors continued 
using the older terminology.12,19,20 
Nevertheless, although PTCH gene alterations 
can be found in up to 85% of OKCs associated with 
nevoid BCC syndrome, they are only found in 30% of 
sporadic cysts.21 In addition, such genetic alterations 
have been reported among several non-neoplastic 
lesions, including dentigerous and orthokeratinised 
odontogenic cysts, thus indicating that neoplasia 
cannot be defined on the basis of a single genetic 
event.21 These molecular/genetic alterations may 
influence the biological behaviour of OKCs without 
the need to define the cyst as a neoplasm, particularly 
as the classification of a lesion as a cyst or tumour 
has a direct impact on its treatment.21,22 For example, 
cystic lesions require more conservative management 
than neoplasms; as such, most KCOT/OKC cases are 
treated using marsupialisation and enucleation rather 
than surgical resection so as to reduce morbidity.21 
Even extensive KCOTs respond to marsupialisation 
and may resolve completely, with the characteristic 
neoplastic epithelial lining being replaced by epithelia 
similar to oral mucosa.23 The resolution of such cysts 
following marsupialisation is not typical of neoplastic 
lesions.21
Pogrel found that initial decompression of a 
KCOT followed by aggressive curettage and peripheral 
ostectomy with methylene blue staining resulted in 
no recurrences of the lesion; however, the longest 
follow-up period in the study was only six years.23 
Similarly, Leung et al. concluded that enucleation 
of KCOTs along with the application of Carnoy’s 
solution resulted in comparatively low rates of surgical 
morbidity and recurrence.24 Hence, these lesions were 
reclassified as cystic lesions rather than odontogenic 
tumours in the 2017 WHO classification.2,21 While 
both OKCs and orthokeratinised odontogenic cysts 
are considered developmental cysts, OKCs behave 
more aggressively.20 
adenomatoid odontogenic tumour
The true nature of adenomatoid odontogenic tumours 
(AOTs) has always been controversial, particularly 
as to whether these lesions should be considered 
hamartomatous growths, true benign neoplasms or 
cystic lesions. This may be due to difficulties regarding 
the precise definitions and overlapping features of 
hamartomas, cysts and cystic neoplasms.25 An AOT 
is sometimes considered to be a hamartoma due to 
its limited size, occurrence at an early age (during 
the second decade of life) and lack of recurrence 
even following incomplete removal. However, the 
arrangement of odontogenic tissue within the lesional 
area is not in line with that of a developmental 
anomaly.25 Researchers who consider AOTs to be 
non-aggressive non-invasive benign neoplasms claim 
that the limited size of most AOT cases is due to the 
fact that they are detected early and removed before 
reaching a clinically-noticeable size.25 
In contrast, Marx et al. proposed that AOTs 
should not be considered tumours but cysts with a 
hamartomatous intraluminal proliferation of epith-
elial cells derived from the Hertwig epithelial root 
sheath.12 However, Rick stated that AOTs were 
benign embryonal neoplasms; he disagreed with the 
change in terminology as the majority of lesions have 
a predominantly solid component instead of a fluid-
filled cavity.25 Similarly, Thakur et al. proposed that the 
term AOT was most apt for this entity.26 A molecular 
study by Razavi et al. showed that the Ki-67 labelling 
index was lower in AOTs as compared to SMAs, 
signifying a hamartomatous nature.27 However, using 
a human androgen receptor gene polymorphism assay, 
Gomes et al. found that AOTs are monoclonal and 
therefore neoplastic.28
squamous odontogenic tumour
The 2005 WHO classification defined squamous 
odontogenic tumours (SOTs) as locally infiltrative 
neoplasms;5 however, Marx et al. considered them to 
be a hamartomatous proliferation of mature epithelial 
cells probably arising from the epithelial cell rests of 
Malassez.12 The occurrence of multicentric SOTs 
may also be indicative of a hamartomatous nature, 
with Leider et al. reporting three cases of familial 
multicentric SOTs among siblings.29
Benign Mixed Epithelial and 
Mesenchymal Odontogenic 
Tumours
As the name implies, these tumours are composed of 
both epithelial and mesenchymal tissue.
odontoma
Philipsen et al. suggested that complex and compound 
odontomas be regarded as two separate entities; 
this position is in contrast to that of Regezi et al., 
who suggested that the classification of complex 
and compound odontomas should be combined 
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for therapeutic reasons.30,31 Nonetheless, as these 
entities differ in their relative frequency, location 
and radiographical presentation, their separation as 
two distinct entities seems to be justified, regardless 
of the fact that both types of odontoma are treated 
conservatively.9 Cases of odontomas have shown 
microscopic features of both types; however, clinical 
data and histological evaluations will, in most cases, 
lead to a diagnosis of either a complex or compound 
odontoma.9 In general, however, there seems to be 
little clinical justification for differentiating these 
two entities.
ameloblastic fibroma
In agreement with the 1992 WHO classification, 
Philipsen et al. confirmed that ameloblastic fibromas 
(AFs)—in particular, those 22.3% developing after 
the age of 20 years—are true benign neoplasms.30,32 
Additionally, AFs which grow during the entire 
odontogenesis period of childhood and adolescence 
may represent non-neoplastic or hamartomatous 
lesions that develop into ameloblastic fibro-odontomas 
(AFOs) or odontomas. Both AFOs and odontomas go 
through stages of mineralisation and calcification; none 
of them arise de novo as calcified lesions.9 On these 
grounds, Philipsen et al. proposed some hypothetical 
theories on the pathogenesis and relationship between 
mixed odontogenic tumours and odontomas and 
suggested that both a neoplastic and hamartomatous 
line of development should be considered to explain 
how mixed odontogenic tumours are formed.30 
As the histopathological appearance of an 
AF in its neoplastic form is indistinguishable from 
that of a developing odontoma, Buchner et al. 
recommended the use of clinical and radiological 
features in distinguishing these lesions.33 Large 
expansile multilocular lesions that exhibit extensive 
bone destruction and cortical perforation in young 
individuals are more likely to be of a neoplastic 
nature, while asymptomatic small unilocular lesions 
in children, when they lie directly over the crown of 
an unerupted tooth with no or minimal expansion 
of bone, are likely to be developing odontomas.33 
In the 2017 classification, the WHO ceased classifying 
ameloblastic fibrodentinomas and AFOs as separate 
entities, with only AFs considered a separate entity.2
primordial odontogenic tumour 
Mosqueda-Taylor et al. reported six cases of a previously 
undescribed odontogenic tumour that presented as 
well-circumscribed pericoronal radiolucencies with 
a dentigerous relationship.34 Microscopically, the 
tumour was composed of immature loose fibrous 
connective tissue resembling dental papillae and the 
periphery was lined by columnar or cuboidal epithelia 
resembling the inner enamel epithelium of a developing 
tooth.34 Due to the unique clinical, radiographical, 
histopathological and immunohistochemical present-
ation of primordial odontogenic tumours, this entity 
was included in the 2017 WHO classification.2 
However, Ide et al. questioned the exact nature of 
this tumour, particularly as to whether it was truly a 
newly recognised embryonal tumour of immature 
dental tissue exhibiting neoplastic characteristics 
of progressive growth or merely an architectural 
morphological variant of an AF or odontogenic 
fibroma (OF)/dentigerous myxoma arising during 
active dental development.35 Future case reports may 
shed more light on this new lesion.
calcifying cystic odontogenic 
tumour/calcifying odontogenic 
cyst
Calcifying odontogenic cysts (COCs) were first 
identified as a specific type of odontogenic lesion by 
Gorlin et al.36 However, controversy has since arisen 
regarding the association between non-neoplastic 
cystic lesions and solid tumour masses with similar 
cellular and histomorphological features. The 1971 
WHO classification described COC tumours as a 
non-neoplastic cystic lesion, while the description 
was updated to state that “most lesions appear to be 
non-neoplastic” in the 1992 edition.32,37 Reichart et al. 
theorised that the lesion had been wrongly classified 
as an epithelial-ectomesenchymal lesion because the 
stroma was not characterised by ectomesenchyme, 
but rather by mature collagenous connective tissue.9 
The nature of the dentinoid material produced 
in COCs has not been fully clarified; however, its 
production is probably not the outcome of true 
induction via a sequence of reciprocal epithelial-
ectomesenchymal interactions but rather as a result of 
the metaplastic process.9 In 2005, the WHO grouped 
COCs with all of their variants as an odontogenic 
tumour rather than a cyst and defined it as a benign 
cystic neoplasm of odontogenic origin characterised 
by ameloblastoma-like epithelia with ghost cells that 
may calcify.12 Dentinogenic ghost cell tumours were 
classified as a separate entity and defined as locally 
invasive neoplasms characterised by ameloblastoma-
like islands of epithelial cells in mature connective 
tissue stroma.5 
However, in a multicentre review of ghost cell 
lesions, Ledesma-Montes et al. found that over 85% 
of calcifying cystic odontogenic tumours were simple 
cysts occurring either alone (65%) or in association 
with odontomas (20%); only a few lesions showed 
ameloblastomatous proliferations, with merely 5% 
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of lesions found to be solid and described as true 
neoplastic dentinogenic ghost cell tumours.38 Similar 
results were observed by Hong et al., who found 
that lesions which presented as simple cysts rarely 
recurred and had a completely benign course.39 Martin 
et al. proposed that simple cystic lesions should be 
considered developmental cysts that may arise alone 
or in association with other developmental lesions, 
such as odontomas, whereas solid lesions showing 
ameloblastomatous proliferations should be regarded 
as neoplasms due to their high recurrence rates.21 
Subsequently, the WHO reclassified dentinogenic 
ghost cell tumours as odontogenic tumours in 2017, 
while excluding cystic lesions such as COCs.2
Benign Mesenchymal 
Odontogenic Tumours
These tumours are derived from mesenchymal tissue 
of dental origin, such as periodontal ligaments, dental 
papillae or dental follicles.9
odontogenic fibroma
Due to their rarity and uncertainty regarding distinct 
types, OFs are often considered to be controversial.9 It 
is worth mentioning that the current widely accepted 
terms—simple type or WHO type/complex central 
OFs—were not used in either the first or second editions 
of the WHO classification; both terms were proposed 
by Gardner.40 Doyle et al. further recommended the 
term complex OF as an alternative to WHO type 
OF.41 In 2005, the WHO divided OFs according to 
two histological types of lesions: epithelium-poor 
(formerly termed simple type OFs) and epithelium-
rich (formerly termed complex or WHO type 
OFs) lesions.5 In 2017, the WHO abandoned the 
epithelium-poor subtype as it was poorly defined and 
documented, with OF instead described as “a rare 
neoplasm of mature fibrous connective tissue, with 
variable amounts of inactive-looking odontogenic 
epithelium with or without evidence of calcification”.4
odontogenic myxoma
Considerable confusion exists regarding the patho- 
genesis of jaw myxomas and whether they are odonto-
genic (i.e. derived from odontogenic mesenchyme) 
or osteogenic (i.e. presumably derived from primitive 
bone tissue).19 While myxomas do occur in the long 
bones, they are rare and are thought to arise from 
the pluripotent mesenchymal stem cells. The jaws 
also contain a small population of non-odontogenic 
pluripotent mesenchymal stem cells that may 
generate myxomas.12,42 Although it is as yet unproven, 
jaw myxomas are thought to originate from the 
odontogenic rather than somatic mesenchyme.12 On 
the other hand, myxomas have been reported in non-
odontogenic sites, such as the sinonasal tract, facial 
bones, extracranial skeleton, upper ramus and the 
condyle of the mandible.42 According to Johnson et al., 
true myxoid tissue is a specific fundamental primary 
tissue in humans and not merely an embryonic 
connective tissue as it performs many functions, is an 
essential component of the mucoperiosteum of the 
paranasal sinuses, cranial sutures and dental papillae 
and may also be responsible for the development of 
myxomas.43 Subclassifying myxomas derived from the 
facial skeleton into odontogenic myxomas (OMs) and 
true osteogenic myxomas may therefore better reflect 
their histogenesis.42
The dental papillae, dental follicles and periodontal 
tissues have been implicated as possible germ centres 
of OMs.1 However, OMs differ from dental papillae or 
dental follicle lesions due to differences in the amount 
and types of proteoglycan present. Hyaluronic acid 
concentrations in OMs have been found to be four 
times higher than other glycosaminoglycans, such 
as chondroitin sulphate.1 This finding is contrary to 
those of mesenchymal tissues from dental pulp, the 
gingivae and the periodontal ligament.1 Adekeye et al. 
suggested that the characteristic histopathology of 
this neoplasm could be due to myxoid changes within 
a pre-existing mesenchymatous lesion or that it may 
represent a degenerative form of OF.44
cementoblastoma
Cementoblastomas are considered the only true 
neoplasms of cemental (odontogenic) origin.9 How-
ever, some researchers have pointed out that the 
histopathological features of jaw cementoblastomas 
are identical to those of osteoblastomas.19 The 
only differentiating feature seems to be that a 
cementoblastoma is attached to the apex of a tooth 
and grows in an expansile pattern with radiating 
osteoid columns growing outwards.18,19
cemento-ossifying fibroma
In the 2005 WHO classification, ossifying fibromas 
were incorporated under bone-related lesions; 
however, the 2017 WHO classification included 
this entity under the category of mesenchymal 
odontogenic tumours instead.2,5 This may be because 
their exclusive occurrence within the jaws and 
probable periodontal origin are suggestive of an 
odontogenic nature. Despite the fact that definitions 
of cementum include its anatomical association with 
tooth roots, Wright et al. proposed that cemento-
ossifying fibroma was the best name for this entity 
because it is a well-understood term and laboratory 
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evidence indicates that periodontal ligament stem cells 
can produce both bone and cementum.22 Morover, the 
term cemento-ossifying fibroma also emphasises that 
the lesion occurs exclusively within the tooth-bearing 
areas of the jaws. However, confusion may still arise 
when differentiating cemento-ossifying fibromas from 
ossifying fibromas of other bones.
Malignant Odontogenic 
Tumours
These lesions are extremely rare as the majority of 
odontogenic tumours are either completely benign or 
only locally aggressive.22 
odontogenic carcinoma 
In the 2017 WHO classification, carcinomas derived 
from the odontogenic epithelia have been categor-
ised in a number of ways, including as ameloblastic 
carcinomas (ACs), primary intraosseous carcin-
omas, sclerosing odontogenic carcinomas, clear-cell 
odontogenic carcinomas (CCOCs) and odonto- 
genic ghost cell carcinomas.2 Metastasising amelo-
blastomas, which were previously considered to 
be malignant odontogenic neoplasms in the 2005 
WHO classification, are now designated as benign 
odontogenic tumours (i.e. ameloblastomas).2,5 The 
practice of subtyping carcinomas as ACs or primary 
intraosseous carcinomas has been abandoned as 
there seems to be no advantage to dividing these rare 
lesions.4 However, some researches have highlighted 
the difficulty in differentiating these two entities 
because of their overlapping histopathological and 
clinical features.22,45,46
clear cell odontogenic 
carcinoma
The existence of a relationship between clear-cell 
ameloblastomas (CCAs) and CCOCs is an interesting 
proposition which has yet to be fully elucidated. 
Piattelli et al. were the first to postulate that CCOCs 
are a distinct and separate entity of ameloblastomas 
and not simply a clear cell variant, whereas Waldron 
et al. maintained that CCOCs and CCAs were part of 
the same histopathological spectrum.47,48 Slater also 
regarded CCA to be a synonym for CCOC, although 
Reichart et al. believed that these lesions should 
be differentiated as two different entities based on 
their distinct demographic, clinical and histological 
features.9,49 Future studies with large sample sizes 
may reveal whether these lesions should be viewed as 
separate entities or variants along a spectrum.
odontogenic ghost cell 
carcinoma
These lesions have been described in a variety of 
ways, including as malignant COCs, odontogenic 
ghost cell carcinomas, carcinomas arising in COCs, 
aggressive epithelial odontogenic ghost cell tumours, 
dentinogenic ghost cell ameloblastomas and malig-
nant calcifying ghost cell odontogenic tumours.9 
Slater considered this entity to be a variant of an AC 
with evidence of ghost cell keratinisation.49 However, 
the mere presence of ghost cells does not necessarily 
dictate the biological behaviour of a lesion; prognosis is 
determined by the tissue that surrounds the ghost cells. 
For example, a benign lesion containing ghost cells will 
exhibit benign biological behaviour, while a carcinoma 
containing ghost cells will behave malignantly.49
sclerosing odontogenic 
carcinoma
These tumours were not included in the 2005 WHO 
classification of odontogenic carcinomas and were 
first proposed as a distinct entity by Koutlas et al.5,50 
The characteristic histopathology includes infiltrating 
‘single file’ thin cords and strands of polyhedral 
neoplastic cells within a stroma of dense sclerosis. 
Koutlas et al. described the tumour as having an 
odontogenic origin, as the immunohistochemical 
profile of the tumour cells exhibited positive CK 
markers (CK5/6, CK19 and weak CK7 stains).50 Despite 
its bland cytological features, the tumour exhibits 
extensive local infiltrative growth into the muscles 
and nerves.51 This newer entity has been included in 
the 2017 WHO classification; however, metastasis has 
not been reported in any of the seven cases described 
to date.2,51 Hence, further study of its biological 
behaviour is required to confirm its placement within 
the category of odontogenic carcinomas.
odontogenic sarcoma
The 2005 WHO classification made a distinction 
between odontogenic sarcomas with (i.e. amelo-blastic 
fibrodentinosarcomas and ameloblastic odonto- 
sarcomas) and without (i.e. ameloblastic fibro-
sarcomas) formation of dental hard structures, which 
is useful when making a histopathological diagnosis.5 
However, this concept has been questioned as the 
biological profile and prognosis of ameloblastic 
fibrodentinosarcomas, ameloblastic odontosarcomas 
and ameloblastic fibrosarcomas appear to be identical.52 
In the 2017 WHO classification, only odontogenic 
sarcomas were mentioned, thereby simplifying this 
category.2
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odontogenic carcinosarcoma
This entity was excluded from the 2005 WHO 
classification as evidence supporting its inclusion 
was questionable; however, recent research has 
reconfirmed its existence and it was once again 
incorporated in the 2017 WHO classification.4,5,53–55
Conclusion
There are a number of controversies currently under 
debate within the field of odontogenic tumours, 
particularly regarding their nomenclature, incidence, 
pathogenesis and histopathological characteristics. 
It is hoped that the elucidation of key controversies 
and recent concepts regarding odontogenic tumours 
presented in this article may help to enhance the 
understanding, diagnosis and treatment of these 
unique lesions.
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